Most PFAS sampling plans name the analytes, the sample points, and the reporting limit. Fewer name the day the result will be in hand, and that omission has consequences. A sample that returns after a budget vote, a customer notice deadline, or a treatment order does not inform the decision it was meant to inform. For a utility, a dealer quoting a treatment train, or a lab scheduling its bench, the result date is part of the design, not an administrative afterthought.
The clock starts before the bottle is filled
Lab turnaround runs through a chain of steps: collection under the method's handling conditions, shipment under temperature and holding-time limits, receipt and logging, preparation, analysis, and then review before a report is released. Each step carries its own delay. A sample collected late in the week, a shipment that misses a pickup, or a batch that needs rework can each push the report date further out than the sampling crew expected. None of this is unusual. It is the reason the plan should count backward from the decision date rather than forward from the sampling date.
Ask the laboratory for its stated turnaround in writing before the first sample is collected, and ask what triggers an expedited or rerun schedule. Record the answer in the sampling plan next to the sample IDs and the site list. If the answer is vague, treat that as information about how much schedule buffer the decision will need.
Reporting limits decide what a result can say
Turnaround is only half the question. The result also has to be readable at the level the decision requires. A study summary from Circle of Blue, dated October 23, 2026, and written by Alissa de Chassey, originally appeared at Inside Climate News. Its headline says PFAS contamination in drinking water may be underestimated. The summary's opening concerns concentrations that "fall below laboratory reporting limits," a condition that changes what a reported value means. The full piece is worth reading in its Circle of Blue summary of the underestimation study.
The practical point does not depend on which direction an underestimate runs. A non-detect is a statement about the method's reporting limit as much as about the water in the pipe. If a planned decision depends on a result near that limit, the schedule should include time for a confirmation sample, and that second sample carries its own turnaround. Two rounds of testing can consume a budget cycle that one round would have fit inside.
A federal strategy does not shorten the queue
Water Finance and Management reported that the U.S. Environmental Protection Agency launched its first agency-wide PFAS Technology, Evaluation, Coordination, and Harmonization (PFAS TECH) strategy at an event in Commerce City, Colorado. According to that report, EPA said the effort will help "springboard technology innovation on PFAS," which points toward research and technology development over the coming period. The Water Finance and Management report on the EPA PFAS TECH strategy sets out the stated goals.
A strategy of this kind sets a direction for technology and research. It does not, by itself, change the turnaround on a sample submitted this month or the order in which a commercial laboratory processes it. Utilities and dealers should read it as a signal about where methods and treatment options may develop, while keeping the sampling calendar tied to the laboratory's current schedule.
Write the decision date into the plan
Before the first bottle goes out, name the decision the result will feed, whether that is a budget approval, a customer notice, a change-out of media, or a choice between treatment approaches. Count backward through shipping, the laboratory queue, review, and any confirmation round. Compare the resulting date with the meeting or order date on the calendar. If the margin is thin, move the sampling forward, not the decision.
Households and small systems weighing point-of-use treatment against a testing window face the same arithmetic. Some ask local RO specialists how a delayed result affects an installation schedule. The treatment choice should not wait on a result if the decision window is short, but the result should still be on the calendar before equipment is ordered.
The result is only as useful as the date it arrives. Put that date in the plan.